Affiliation:
1. Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Abstract
ABSTRACT
Metastatic disease is the leading cause of death in cancer patients. Metastasis formation involves a cascade of events for which the underlying mechanisms are still poorly understood. During the metastatic cascade, cancer cells tightly interact with the immune system and they influence each other, both in the tumor microenvironment and systemically. The crosstalk between cancer and immune cells adds another layer of complexity to our understanding of metastasis formation, but at the same time opens new therapeutic opportunities for cancer patients. The intensifying development of immunotherapeutic strategies calls for a better understanding of immune regulation of metastasis in order to maximize the therapeutic benefit for patients with metastatic disease. In this Review and accompanying poster, we describe the main mechanisms of immune regulation of metastasis that have been reported to date, and present promising immunotherapeutic options that are currently available, or may become so in the near future, to tackle metastasis.
Funder
KWF Kankerbestrijding
European Research Council
Oncode Institute
Beug Foundation for Metastasis Research
EMBO
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Publisher
The Company of Biologists
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology (miscellaneous),Medicine (miscellaneous),Neuroscience (miscellaneous)
Reference193 articles.
1. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment;Acuff;Cancer Res.,2006
2. IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients;Ahmadzadeh;Blood,2005
3. The checkpoint immunotherapy revolution;Alexander;Pharm. Ther.,2016
4. Lymphangiogenesis in development and human disease;Alitalo;Nature,2005
5. Clinical significance of defective dendritic cell differentiation in cancer clinical significance of defective dendritic cell differentiation;Almand;Clin. Cancer Res.,2000
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献